68Ga-Pentixather

N/A

Report date: 2025/11/20 16:00:41
NME

Base Information

Drug Name68Ga-Pentixather
Drug Alias Name68Ga-Pentixather
ClassificationRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4] 
Mechanisms of ActionC-X-C motif chemokine receptor 4 antagonists
TargetsC-X-C motif chemokine receptor 4
Therapy Area/IndicationsSmall Cell Lung CarcinomaMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFranceMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesPeking Union Medical College Hospital
China Registration ClassN/A

Develop Information

Active CompaniesPeking Union Medical College HospitalInstitut De Cancerologie De L Ouest
Inactive CompaniesN/A
Active IndicationsSmall Cell Lung CarcinomaMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A